Jazz Pharmaceuticals up Over 5% on Overweight Initiation

by Eddie Staley, Benzinga Editor
July 14, 2011 11:35 AM | 13 seconds read |
Jazz Pharmaceuticals JAZZ is up over 5% on a rating initiation from this morning. Piper Jaffray initiated the company with Overweight and price target of $51 JAZZ Pharmaceuticals is currently trading at $36.84, a gain of 5.32%
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Intraday UpdateMoversHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!